INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 April 2011
Total net assets |
£102.9m |
NAV per share |
176.1p |
Share price |
153.5p |
Total value of unquoted investments |
£24.3m |
Total number of portfolio companies |
59 |
Cash |
(4)% NAV |
Cash committed and reserved to unquoted investments |
8% NAV |
Portfolio companies with < 1 year of cash |
12% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen |
6.19 |
Shire Ltd |
6.14 |
Celgene |
5.81 |
Cadent |
5.31 |
Insulet |
4.77 |
Gilead Sciences |
4.64 |
Teva |
4.27 |
Micromet |
4.12 |
Biomarin |
2.9 |
Alexion |
2.9 |
|
----------- |
Total |
47.05 |
Geographical Allocation |
% |
United States |
73 |
Europe |
25 |
Middle East |
4 |
Australia |
2 |
Cash |
(4) |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
80 |
Unquoted |
24 |
Cash |
(4) |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
17 MAY 2011